back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-27 13:54 Tx date 2026-03-06 |
$DTC
Defence Therapeutics Inc. |
Rifai, Omar
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+5,000,000 vol |
5,750,000 | |
| Filed 2026-03-27 13:54 Tx date 2026-03-06 |
$DTC
Defence Therapeutics Inc. |
Rifai, Omar
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2026-03-27 13:53 Tx date 2026-03-06 |
$DTC
Defence Therapeutics Inc. |
Rifai, Omar
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,750,000
+5,000,000 vol $0.55 each |
5,750,000 | |
| Filed 2026-03-27 13:53 Tx date 2026-03-06 |
$DTC
Defence Therapeutics Inc. |
Rifai, Omar
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2025-12-16 12:43 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Selivanova, Svetlana
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
| Filed 2025-12-16 10:29 Tx date 2025-09-16 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-16 10:28 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
| Filed 2025-12-16 10:26 Tx date 2025-09-16 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-09-22 10:05 Tx date 2025-09-16 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-15 15:28 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,400,000 | |
| Filed 2025-12-10 17:21 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
||
| Filed 2025-12-11 16:42 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-11 16:39 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Holder: Gestion Philippe Lefrancois Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
| Filed 2025-12-11 16:33 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
||
| Filed 2025-12-11 16:28 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-11 14:37 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
450,000 | |
| Filed 2025-12-10 17:21 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,400,000 | |
| Filed 2025-09-22 10:05 Tx date 2025-09-16 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-02-04 15:08 Tx date 2025-01-31 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
1,000,000 | |
| Filed 2025-02-03 16:16 Tx date 2025-01-31 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
250,000 |